Snapshot from Jul 01, 2026 at 07:00 UTC. For live data and tracking: View Live
Business share repurchase

dsm-firmenich Share Repurchase Program Progress

Analysis based on 10 articles · First reported Jun 02, 2026 · Last updated Jun 30, 2026

Sentiment
40
Attention
3
Articles
10
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The share repurchase program by DSM-Firmenich is generally viewed positively by the market as it reduces the number of outstanding shares, potentially increasing earnings per share and stock value. This action directly impacts the stock price of DSM-Firmenich and signals confidence from the company's management.

Nutrition Health Beauty

DSM-Firmenich, a Swiss company listed on Euronext Amsterdam and SIX Swiss Exchange, announced on February 9, 2026, its intention to repurchase ordinary shares with an aggregate market value of €500 million to reduce its issued capital. Additionally, €40 million worth of shares were repurchased to cover commitments under the Group's share-based compensation plans, which was finalized on March 23, 2026. The company commenced repurchasing shares on March 12, 2026, for a total amount of €540 million. Weekly updates indicate ongoing progress, with 437,000 shares repurchased between June 1-5, 2026, for €30.0 million, and 184,000 shares between May 25-29, 2026, for €13.3 million. The €500 million program is expected to be completed by the end of Q3 2026.

70 DSM-Firmenich announced intention to repurchase
stock
DSM-Firmenich is repurchasing its own shares to cover compensation plans and reduce issued capital, which can positively impact its stock price and shareholder value.
Importance 100 Sentiment 50
exch
DSM-Firmenich is listed on Euronext Amsterdam, where its share repurchase program transactions are reported.
Importance 20 Sentiment 0
exch
DSM-Firmenich is listed on SIX Swiss Exchange, where its share repurchase program transactions are reported.
Importance 20 Sentiment 0
loc
The share repurchase program is valued in Europe, indicating the currency of the transactions.
Importance 10 Sentiment 0
cnt
DSM-Firmenich is a Swiss company, indicating its country of origin and primary regulatory environment.
Importance 10 Sentiment 0
cnt
DSM-Firmenich has operations in the Netherlands, and press releases are issued from Maastricht, Netherlands.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.